Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Express Scripts (ESRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,064,128
  • Shares Outstanding, K 562,120
  • Annual Sales, $ 100,065 M
  • Annual Income, $ 4,517 M
  • 36-Month Beta 0.99
  • Price/Sales 0.53
  • Price/Cash Flow 9.02
  • Price/Book 2.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 2.42
  • Number of Estimates 11
  • High Estimate 2.43
  • Low Estimate 2.40
  • Prior Year 1.90
  • Growth Rate Est. (year over year) +27.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.78 +10.05%
on 09/05/18
96.45 -2.13%
on 09/17/18
+6.49 (+7.38%)
since 08/24/18
3-Month
72.00 +31.11%
on 08/01/18
96.45 -2.13%
on 09/17/18
+15.17 (+19.15%)
since 06/22/18
52-Week
55.80 +69.18%
on 10/18/17
96.45 -2.13%
on 09/17/18
+32.11 (+51.55%)
since 09/22/17

Most Recent Stories

More News
Webb County, Texas, and Two Teamsters Health & Welfare Funds Seek Federal Court Injunction for Top Three Pharmacy Benefit Managers To Take Immediate Steps to Address Country's Opioid Crisis

A small county in south Texas joined by two Employer-Teamsters Locals filed a joint motion in federal court on Friday seeking an injunction directing the nation's three largest prescription drug plan providers,...

ESRX : 94.40 (-0.19%)
Express Scripts Earns Highest Overall Customer Satisfaction Rating According to Independent Survey of Plan Sponsors

According to the Pharmacy Benefit Management Institute's (PBMI) 2018 PBM Customer Satisfaction Report of plan sponsors, Express Scripts leads the industry in customer satisfaction, earning the highest...

ESRX : 94.40 (-0.19%)
Cigna Moves Closer to Express Scripts Buyout With DoJ Nod

Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.

AET : 203.40 (-0.43%)
CVS : 78.74 (-1.07%)
ESRX : 94.40 (-0.19%)
CI : 203.24 (+0.50%)
U.S. Department of Justice Grants Clearance to Cigna's Acquisition of Express Scripts

Cigna Corporation (NYSE: CI) ("Cigna")and Express Scripts Holding Company (NASDAQ: ESRX) ("Express Scripts") today announced that the Antitrust Division of the United States Department of...

ESRX : 94.40 (-0.19%)
CI : 203.24 (+0.50%)
Express Scripts Set to Possibly Pullback After Yesterday's Rally of 1.69%

Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $91.52 to a high of $93.38. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of...

ESRX : 94.40 (-0.19%)
SmarTrend Watching for Potential Pullback in Shares of Express Scripts After 1.69% Gain

Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $91.52 to a high of $93.38. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of...

ESRX : 94.40 (-0.19%)
Express Scripts Implements Emergency Procedures for Affected Members in Advance of Hurricane Florence

In advance of the expected landfall later this week of Hurricane Florence, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication...

ESRX : 94.40 (-0.19%)
Top 5 Companies in the Health Care Services Industry with the Best Relative Performance (CVS , DPLO , ESRX , PINC , EVHC )

Here are the top 5 stocks in the Health Care Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

CVS : 78.74 (-1.07%)
ESRX : 94.40 (-0.19%)
DPLO : 19.12 (-6.46%)
Cigna Corporation Announces Pricing of $20 Billion of Senior Notes

Cigna Corporation (NYSE: CI) ("Cigna") today announced that Halfmoon Parent, Inc. (the "Issuer"), a direct wholly owned subsidiary of Cigna, priced an offering (the "Offering") of $1,000,000,000...

ESRX : 94.40 (-0.19%)
CI : 203.24 (+0.50%)
A.M. Best Removes From Under Review with Negative Implications and Affirms Credit Ratings of Cigna Corporation and Its Insurance Subsidiaries

A.M. Best has removed from under review with negative implications and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR)...

ESRX : 94.40 (-0.19%)
CI : 203.24 (+0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ESRX with:

Business Summary

Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy...

See More

Key Turning Points

2nd Resistance Point 95.27
1st Resistance Point 94.83
Last Price 94.40
1st Support Level 93.98
2nd Support Level 93.57

See More

52-Week High 96.45
Last Price 94.40
Fibonacci 61.8% 80.92
Fibonacci 50% 76.13
Fibonacci 38.2% 71.33
52-Week Low 55.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar